BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24330588)

  • 21. A case-control study to evaluate the impact of the breast screening programme on mortality in England.
    Maroni R; Massat NJ; Parmar D; Dibden A; Cuzick J; Sasieni PD; Duffy SW
    Br J Cancer; 2021 Feb; 124(4):736-743. PubMed ID: 33223536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammography screening and risk of breast cancer death: a population-based case-control study.
    Otto SJ; Fracheboud J; Verbeek AL; Boer R; Reijerink-Verheij JC; Otten JD; Broeders MJ; de Koning HJ;
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):66-73. PubMed ID: 22147362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of organised mammography screening on breast cancer mortality in a case-control and cohort study.
    Heinävaara S; Sarkeala T; Anttila A
    Br J Cancer; 2016 Apr; 114(9):1038-44. PubMed ID: 27010748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer screening halves the risk of breast cancer death: a case-referent study.
    Paap E; Verbeek AL; Botterweck AA; van Doorne-Nagtegaal HJ; Imhof-Tas M; de Koning HJ; Otto SJ; de Munck L; van der Steen A; Holland R; den Heeten GJ; Broeders MJ
    Breast; 2014 Aug; 23(4):439-44. PubMed ID: 24713277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 1996; 3(4):200-3. PubMed ID: 9041485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
    Young KC; Wallis MG; Blanks RG; Moss SM
    Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.
    Blanks RG; Wallis MG; Moss SM
    J Med Screen; 1998; 5(4):195-201. PubMed ID: 9934650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
    Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.
    Fielder HM; Warwick J; Brook D; Gower-Thomas K; Cuzick J; Monypenny I; Duffy SW
    J Med Screen; 2004; 11(4):194-8. PubMed ID: 15563774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of outcome of mammography in the National Health Service Breast Screening Programme.
    Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M
    J Med Screen; 2002; 9(2):74-82. PubMed ID: 12133927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland.
    Anttila A; Koskela J; Hakama M
    J Med Screen; 2002; 9(4):153-8. PubMed ID: 12518004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.